Janssen Pharmaceutica
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- -
- Established
- 1953-01-01
- Employees
- 10K
- Market Cap
- -
A Post Marketing Surveillance Study on the Safety and Effectiveness of Prucalopride in the Treatment of Chronic Constipation
- First Posted Date
- 2012-09-25
- Last Posted Date
- 2015-12-02
- Lead Sponsor
- Janssen Pharmaceutica
- Registration Number
- NCT01692132
A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I Infection
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2012-09-25
- Last Posted Date
- 2015-12-02
- Lead Sponsor
- Janssen Pharmaceutica
- Registration Number
- NCT01692470
A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2012-09-25
- Last Posted Date
- 2015-12-02
- Lead Sponsor
- Janssen Pharmaceutica
- Registration Number
- NCT01692457
Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia
- First Posted Date
- 2012-08-10
- Last Posted Date
- 2014-05-05
- Lead Sponsor
- Janssen Pharmaceutica
- Target Recruit Count
- 1117
- Registration Number
- NCT01662648
Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain
- First Posted Date
- 2012-07-24
- Last Posted Date
- 2013-10-11
- Lead Sponsor
- Janssen Pharmaceutica
- Target Recruit Count
- 20
- Registration Number
- NCT01648699
A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia
- First Posted Date
- 2012-05-25
- Last Posted Date
- 2012-10-22
- Lead Sponsor
- Janssen Pharmaceutica
- Target Recruit Count
- 188
- Registration Number
- NCT01606228
© Copyright 2024. All Rights Reserved by MedPath